| [1] |
顾东风，姜广勇．中国慢性心力衰竭流行病学和治疗现状[J]. 中华心血管病杂志，2003, 31(1)：3-6.
|
| [2] |
Lu J Y, Huang K C, Chang L C, et al. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond[J]. J Biomed Sci, 2008, 15(5): 565-576.
|
| [3] |
Yamaji M, Tsutamoto T, Tanaka T, et al. Effect of carvedilol on plasma adiponectin concentration in patients with chronic heart failure[J]. Circ J, 2009, 73(6): 1067-1073.
|
| [4] |
Van Berendoncks AM, Beckers P. Beta-blockers modify the prognostic value of adiponectin in chronic heart failure[J]. Int J Cardiol, 2010, 11(6): 567-572.
|
| [5] |
Van Berendoncks AM, Beckers P, Hoymans VY, et al. Exercise training reduces circulating adiponectin levels in patients with chronic heart failure[J]. Clin Sci(Lond), 2010, 118(4): 281-289.
|
| [6] |
Kadowaki T, Yamauchi T, Kubota N, et al. Adiponectin andadiponectin receptors in insulin resistance, diabetes, and themetabolic syndrome[J]. J Clin Invest, 2006, 116(7): 1784-1792.
|
| [7] |
Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects[J]. Nature, 2005, 423(6941): 762-769.
|
| [8] |
Liao Y, Takashima S, MaedaN, et al. Exacerbation of heart failure in adiponectin deficientmice due to impaired regulation of AMPK and glucose metabolism[J]. Cardiovasc Res, 2005, 67(4): 705-713.
|
| [9] |
Ding G, Qin Q, He N, et al. Adiponectin and its recep tors are ex-p ressed in adult ventricular cardiomyocytes and up regulated by ac-tivation of peroxisome p roliferator activated recep tor gamma[J]. J Mol Cell Cardiol, 2007, 43(1): 73-84.
|
| [10] |
Park JH, Lee M, Kim SW, et al. Non-viral adiponectin gene therapy into obese type 2 diabetic mice ameliorates insulin resistance[J]. J Control Release, 2006, 114(1): 118-125.
|
| [11] |
Yamauchi T, Kamon J, Waki H, et al. Globular adiponectin protected ob/ob mice from diabetes and apoE-deficient mice from atherosclerosis[J]. J Biol Chem, 2003, 278(4): 2461-2468.
|
| [12] |
Nørrelund H, Wiggers H, Halbirk M, et al. Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure[J]. J intern Med, 2006, 10(1): 11-21.
|
| [13] |
Tsujino T, Kawasaki D, Masuyama T, et al. Left ventricular diastolic dysfunction in diabeti patients[J]. Am J cardiovasc Drugs, 2006, 6(4): 219-230.
|
| [14] |
Paolisso G, Gambardella A, Galzerano D, et al. Total-body and myocardial substrate oxidation in congestive heart failure[J]. Metabolism, 1994, 43: 174-197.
|
| [15] |
Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure[J]. Circulation, 2005, 112(12): 1756-1762.
|
| [16] |
George J, Patal S, Wexler D. Circulating adiponectin concentrations in patients with congestive heart failure[J]. Heart, 2006, 92(10): 1420-1424.
|
| [17] |
Nishiyama Y, Morita H, Harada H, et al. Systolic blood pressure response to exercise as a predictor of mortality in patients with chronic heart failure[J]. Int Heart J, 2010, 51(2): 111-115.
|
| [18] |
impaired regulation of AMPK and glucose metabolism[J]. Cardiovasc Res, 2005, 67(4): 705-713.
|
| [19] |
Ding G, Qin Q, He N, et al. Adiponectin and its recep tors are expressed in adult ventricular cardiomyocytes and up regulated by activation of peroxisome proliferator activated recep tor gamma [J]. J Mol Cell Cardiol, 2007, 43(1): 73-84.
|
| [20] |
Araújo JP, Lourenco P, Rocha-Goncalves F, et al. Adiponectin is increased in cardiac cachexia irrespective of body mass index[J]. Eur J Heart Fail, 2009, 11(6): 567-572.
|
| [21] |
Tsukamoto O, Fujita M, Kato M, et al. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure[J]. J Am Coll Cardiol, 2009, 53(22): 2070-2077.
|